Tagged cancer-therapy
Press Release
Philogen Announces Publication of Best-in-Class FAP-Targeting Small Molecule Ligand (OncoFAP) in PNAS
(i) Study shows impressive tumor uptake of OncoFAP with unprecedented selectivity against healthy organs - (ii) OncoFAP-based molecules are currently being developed for the imaging and therapy of cancer Read More
Press Release
Philogen Announces Publication of the Construction and Application of an Innovative DNA-Encoded Chemical Library in Nature Chemistry
(i) Study shows the generation of a high-quality stereo- and regiodefined DNA-encoded chemical library - (ii) Identified ligands against tumor-associated antigens can serve as vehicles for pharmacodelivery applications Read More
Press Release
Philogen Announces Participation to the 10th World Congress of Melanoma
(i) Philogen will give a poster presentation about the phase II study of Daromun (Nidlegy) for the treatment of non-melanoma skin cancer - (ii) Study shows promising early signs of efficacy in patients with basal cell carcinoma Read More
Press Release
Philogen Announces the Completion of a Second Interim Analysis of Its Phase III Clinical Program With Nidlegy for the Treatment of Melanoma
Nidlegy was found to be well-tolerated and 149 out of the anticipated 214 patients have been safely treated. Data Safety Monitoring Board recommends to continue the study as planned. Read More
Press Release
Fluid Strength™ Launches, FS Double Helix Water
Fluid Strength announces the limited availability of FS Double Helix Water™ to the public after two decades of research and development related to health, cancer, arthritis,diabetes,immune system,sports performance,energy,as well as overall wellnes Read More
Press Release